Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

Russell Skibsted Filing Activity

Latest reported as Chief Financial Officer of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
5
Reported companies
1
Net open-market value
$29,458
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Financial OfficerOpen Market Purchase2,654$2.22$5,892
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Financial OfficerOpen Market Purchase2,292$2.57$5,890
May 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Financial OfficerOpen Market Purchase1,984$2.97$5,892
Subscribe to see more data